In glioblastoma multiforme, inhibiting SREBP2 function has been shown to block lipid biosynthesis in hypoxic cancer cells, impairing their survival under hypoxic conditions (Lewis et al., 2015). The gene discussed is SREBF2; the disease is cancer.